BRIEF published on 04/17/2024 at 07:35, 1 year 10 months ago Legal Finance SE prend des mesures contre les casinos en ligne illégaux Finance Juridique SE La Protection Des Consommateurs Casinos En Ligne Droit Allemand Décisions De Justice
BRIEF published on 04/17/2024 at 07:35, 1 year 10 months ago Evotec Appoints Aurélie Dalbiez as Chief People Officer Chief People Officer Human Resources Corporate Leadership Evotec Aurélie Dalbiez
BRIEF published on 04/17/2024 at 07:35, 1 year 10 months ago Evotec nomme Aurélie Dalbiez au poste de Chief People Officer Ressources Humaines Evotec Direction D'entreprise Aurélie Dalbiez Directeur Des Ressources Humaines
BRIEF published on 04/17/2024 at 07:20, 1 year 10 months ago Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
BRIEF published on 04/17/2024 at 07:20, 1 year 10 months ago Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRIEF published on 04/17/2024 at 07:20, 1 year 10 months ago Kinarus Therapeutics Announces FY2023 Financial Results and Upcoming Business Changes Financial Statements Business Combination Kinarus Therapeutics Reverse Share Split Annual Report Extension
BRIEF published on 04/17/2024 at 07:20, 1 year 10 months ago Kinarus Therapeutics annonce ses résultats financiers pour l'exercice 2023 et les changements commerciaux à venir États Financiers Kinarus Thérapeutique Combinaison Commerciale Fractionnement Inversé Des Actions Extension Du Rapport Annuel
BRIEF published on 04/17/2024 at 07:14, 1 year 10 months ago R&S Group Delivers Strong Annual Results for 2023 and Confirms Positive Outlook for 2024 Dividend Proposal Acquisition Strategy Annual Report 2023 Sustainability Initiatives R&S Group Financial Results
BRIEF published on 04/17/2024 at 07:14, 1 year 10 months ago R&S Group réalise de solides résultats annuels pour 2023 et confirme des perspectives positives pour 2024 Rapport Annuel 2023 Stratégie D'acquisition Proposition De Dividende Initiatives De Durabilité Résultats Financiers Du Groupe R&S
BRIEF published on 04/17/2024 at 07:05, 1 year 10 months ago HomeToGo Successfully Concludes Share Tender Offer Share Buyback Investor Relations Stock Market Tender Offer HomeToGo SE
Published on 03/12/2026 at 13:16, 1 hour 43 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 1 hour 59 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 2 hours 29 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 2 hours 29 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 14:40, 18 minutes ago J.S. Held Launches AI Disputes Monitor to Track Rapidly Growing AI Litigation Landscape
Published on 03/12/2026 at 14:28, 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/12/2026 at 13:51, 1 hour 7 minutes ago REPLY: The Board of Directors approved the draft financial statements for the year 2025
Published on 03/12/2026 at 10:55, 4 hours 3 minutes ago Déclaration des transactions sur actions propres réalisées le 09/03/2026
Published on 03/12/2026 at 10:55, 4 hours 3 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 08:30, 6 hours 29 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 7 hours 29 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 7 hours 29 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA
